Delivery Order SPE2DB20D3505-SPE2DB24FU1T5
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,963.62, is for the delivery of the medication Dupixent 300 mg/2 ml pen, with a completion date of April 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $13,675.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period extending through April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pen medication. The contract is a firm fixed-price delivery order with a ceiling value of $21,505.12 and a performance period through April 23, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $31,119.15, is a delivery order for the supply of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price pricing type and runs through June 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,457.59 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,690.33 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The contract has a period of performance through July 23, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,702.09 Firm Fixed Price Delivery Order contract is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The contract has an ultimate completion date of June 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,126.52, is for the delivery of the specialty medication Dupixent 300 mg/2 ml pen. The contract is a firm fixed price delivery order with an ultimate completion date of October 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award, valued at $14,538.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a period of performance through April 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
- This federal contract award, valued at $19,241.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 9, 2024. The contract is for the delivery of Dupixent 300 mg/2 ml pen (2 ml) and has an ultimate completion date of April 10, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FU1T5Delivery Order
This federal contract award, with ID SPE2DB20D3505|SPE2DB24FU1T5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a specialty medication, with a ceiling value of $13,063.17 and a period of performance through April 30, 2024. The contract is a delivery order, with a firm fixed price pricing type. It is not set aside for any specific business category. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov). In addition to this specific contract, AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 4/29/24 |